Rhythm Pharmaceuticals Share Price (NASDAQ: RYTM)

$97.71

▲

1.23

(1.27%)

Last updated on August 16, 2025 at 1:29 AM IST

$₹

Check the interactive Rhythm Pharmaceuticals Stock chart to analyse performance

Rhythm Pharmaceuticals stock performance

as on August 16, 2025 at 1:29 AM IST

Today's Low:$96.01
Today's High:$97.71
$97.71
1.74%
Downside
Day's Volatility :1.74%
Upside
0.0%
52 Weeks Low:$43.57
52 Weeks High:$99.04
$97.71
55.41%
Downside
52 Weeks Volatility :56.01%
Upside
1.34%

Rhythm Pharmaceuticals Stock Returns

Period	Rhythm Pharmaceuticals Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	59.46%	2.3%	0.0%
6 Months	69.71%	-5.9%	0.0%
1 Year	111.96%	-10.9%	0.0%
3 Years	304.26%	1.7%	-12.4%

Rhythm Pharmaceuticals Inc Key Stats

Check Rhythm Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$96.48
Open	$96.13
Today's High	$97.71
Today's Low	$96.01
Market Capitalization	$6.4B
Today's Volume	$522.3K
52 Week High	$99.04
52 Week Low	$43.57
Revenue TTM	$156.3M
EBITDA	$-175.9M
Earnings Per Share (EPS)	$-3.01
Profit Margin	-117.16%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-116.97%

Stock Returns calculator for Rhythm Pharmaceuticals Stock including INR - Dollar returns

The Rhythm Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Rhythm Pharmaceuticals investment value today

Current value as on today

₹2,16,254

Returns

₹1,16,254

(+116.25%)

Returns from Rhythm Pharmaceuticals Stock

₹1,12,044 (+112.04%)

Dollar Returns*

₹4,210 (+4.21%)

Indian investors sentiment towards Rhythm Pharmaceuticals Stock

-73%

Period: Jul 16, 2025 to Aug 15, 2025. Change in 30 Days versus previous period

Search interest for Rhythm Pharmaceuticals Stock from India on INDmoney has decreased by -73% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Rhythm Pharmaceuticals Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
10.34%
RA Capital Management, LLC
9.18%
PRIMECAP Management Company
8.73%
Baker Bros Advisors LP
8.46%
Vanguard Group Inc
5.20%
NEA Management Company, LLC
4.39%

Analyst Recommendation on Rhythm Pharmaceuticals Stock

Rating

Trend

Buy

93%Buy

6%Hold

0%Sell

Based on 15 Wall street analysts offering stock ratings for Rhythm Pharmaceuticals(by analysts ranked 0 to 5 stars)

Rhythm Pharmaceuticals Share Price Target

What analysts predicted

Upside of 15.14%

Target:

$112.50

Current:

$97.71

Rhythm Pharmaceuticals share price target is $112.50, a slight Upside of 15.14% compared to current price of $97.71 as per analysts' prediction.

Rhythm Pharmaceuticals Stock Insights

Price Movement
In the last 3 months, RYTM stock has moved up by 63.0%
Increasing Revenue
Revenue is up for the last 2 quarters, 32.70M → 48.50M (in $), with an average increase of 32.6% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -49.49M → -46.63M (in $), with an average increase of 6.2% per quarter

Rhythm Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Rhythm Pharmaceuticals is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Rhythm Pharmaceuticals Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Rhythm Pharmaceuticals Inc	7.71%	69.71%	111.96%	304.26%	400.1%
Regeneron Pharmaceuticals, Inc.	5.56%	-14.62%	-50.77%	-8.76%	-6.46%
Beone Medicines Ltd	10.75%	35.05%	65.2%	78.83%	43.89%
Vertex Pharmaceuticals Incorporated	-15.21%	-15.0%	-17.71%	31.27%	43.45%
Alnylam Pharmaceuticals, Inc.	38.29%	79.61%	67.4%	101.24%	219.14%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Rhythm Pharmaceuticals Inc	NA	NA	NA	-2.95	-1.17	-0.29	NA	-0.19
Regeneron Pharmaceuticals, Inc.	14.03	14.03	1.14	39.47	0.15	0.07	0.0	287.55
Beone Medicines Ltd	NA	NA	NA	2.43	-0.05	-0.01	NA	34.32
Vertex Pharmaceuticals Incorporated	27.78	27.78	0.58	18.05	0.23	0.13	NA	67.02
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	3.92	-2.58	-0.03	NA	1.91

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Rhythm Pharmaceuticals Inc	Buy	$6.4B	400.1%	NA	-117.16%
Regeneron Pharmaceuticals, Inc.	Buy	$59.0B	-6.46%	14.03	31.37%
Beone Medicines Ltd	NA	$37.5B	43.89%	NA	-3.89%
Vertex Pharmaceuticals Incorporated	Buy	$100.1B	43.45%	27.78	31.86%
Alnylam Pharmaceuticals, Inc.	Buy	$58.0B	219.14%	NA	-12.96%

Rhythm Pharmaceuticals Dividend announcements

Rhythm Pharmaceuticals Earnings
Rhythm Pharmaceuticals’s price-to-earnings ratio stands at None

About Rhythm Pharmaceuticals Inc

Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases. The company's lead product candidate is IMCIVREE (setmelanotide), a rare melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1, leptin receptor (LEPR) deficiency obesity, and Bardet-Biedl and Alström syndrome. It is in Phase 3 clinical trials for treating POMC or LEPR heterozygous deficiency obesities, steroid receptor coactivator 1 deficiency obesity, SH2B1 deficiency obesity, MC4 receptor deficiency obesity, and other MC4R disorders. The company has licensing agreements with LG Chem, Ltd; Ipsen Pharma S.A.S; Camurus; RareStone Group Ltd.; joint research collaboration with Axovia Therapeutics for developing in bardet-biedl syndrome; and LG Chem, Ltd. The company was formerly known as Rhythm Metabolic, Inc. and changed its name to Rhythm Pharmaceuticals, Inc. in October 2015. The company was founded in 2008 and is headquartered in Boston, Massachusetts.

Organization	Rhythm Pharmaceuticals
Employees	283
CEO	Dr. David P. Meeker M.D.
Industry	Health Technology

Key Management of Rhythm Pharmaceuticals Inc

Name	Title
Dr. David P. Meeker M.D.	Chairman, President & CEO
Mr. Hunter C. Smith M.B.A.	CFO & Treasurer
Mr. Joseph Shulman	Chief Technical Officer
Mr. Yann Mazabraud	Executive VP & Head of International
Ms. Jennifer Lee	Executive VP & Head of North America
Dr. Alastair Garfield Ph.D.	Chief Scientific Officer
Mr. David Connolly	Head of Investor Relations & Corporate Communications
Mr. Jim Flaherty	Senior VP & General Counsel
Ms. Sarah Ryan	Vice President of Sales & Marketing
Ms. Pamela J. Cramer	Chief Human Resources Officer

Important FAQs about investing in RYTM Stock from India :

What is Rhythm Pharmaceuticals share price today?

Rhythm Pharmaceuticals share price today is $97.71 as on August 16, 2025 at 1:29 AM IST at the close of the market. Rhythm Pharmaceuticals share today touched a day high of $97.71 and a low of $96.01.

What is the 52 week high and 52 week low for Rhythm Pharmaceuticals share?

Rhythm Pharmaceuticals share touched a 52 week high of $99.04 and a 52 week low of $43.57. Rhythm Pharmaceuticals stock price today, August 16, 2025 at 1:29 AM IST is trending at $97.71, lower by 1.34% versus the 52 week high.

How to invest in Rhythm Pharmaceuticals Stock (RYTM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Rhythm Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Rhythm Pharmaceuticals Shares that will get you 0.0154 shares as per Rhythm Pharmaceuticals share price of $97.71 per share as on August 16, 2025 at 1:29 AM IST.

What is the minimum amount required to buy Rhythm Pharmaceuticals Stock (RYTM) from India?

Indian investors can start investing in Rhythm Pharmaceuticals (RYTM) shares with as little as ₹87.492 or $1 (as of August 16, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹874.92 in Rhythm Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 16, 2025). Based on Rhythm Pharmaceuticals share’s latest price of $97.71 as on August 16, 2025 at 1:29 AM IST, you will get 0.1023 shares of Rhythm Pharmaceuticals. Learn more about fractional shares .

What are the returns that Rhythm Pharmaceuticals has given to Indian investors in the last 5 years?

Rhythm Pharmaceuticals stock has given 400.1% share price returns and 17.06% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?